Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis

By sjmartinez • July 22, 2024

James WA, Rosenberg AL, Wu JJ, Hsu S, Armstrong A, Wallace EB, Lee LW, Merola J, Schwartzman S, Gladman D, Liu C, Koo J, Hawkes JE, Reddy S, Prussick R, Yamauchi P, Lewitt M, Soung J, Weinberg J, Lebwohl M, Glick B, Kircik L, Desai S, Feldman SR, Zaino ML. Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2024 Aug;91(2):251.e1-251.e11. doi: 10.1016/j.jaad.2024.03.008. Epub 2024 Mar 17. PMID: 38499181.

Tags: abatacept, acitretin, apremilast, biologic, cyclosporine, Dermatology, IL-12/23 inhibitor, IL-17 inhibitor, IL-23 inhibitor, immunosuppressant, methotrexate, Perioperative, psoriasis, psoriatic arthritis, Publications, tofacitinib, tumor necrosis factor-alfa inhibitors

Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

Armstrong AW, Riedl E, Brunner PM, Piaserico S, Visser WI, Haustrup N, Konicek BW, Kadziola Z, Nunez M, Brnabic A, Schuster C. Identifying Predictors of[...]

Reticulated pigmentary changes and Terry’s nails in a patient with a TERT variant-associated telomere biology disorder

Noveir SD, Galamgam J, Pithadia D, Truong A, Hogeling M, Cheng CE. Reticulated pigmentary changes and Terry's nails in a patient with a TERT variant-associated[...]

Clinical consequences of age-related skin barrier dysfunction. Part I. Structural, molecular and physiologic changes with cutaneous aging

Wahhab R, Sanders M, Kokikian N, Ni C, Vandiver AR. Clinical consequences of age-related skin barrier dysfunction. Part I. Structural, molecular and physiologic changes with[...]